Trans­paren­cy: FDA to re­lease more in­fo on pre­mar­ket re­views

The FDA on Wednes­day sought com­ments on a new ef­fort to pro­vide more clar­i­ty on the agency’s phar­ma­ceu­ti­cal ap­pli­ca­tion re­view and de­ci­sion-mak­ing process.

FDA …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER